Table 23-13.

Quality of Care by Race/Ethnicity and Sex in the GWTG-Stroke Program, 2013

Quality-of-Care MeasureWhiteBlackHispanicMaleFemale
IV tPA in patients who arrived ≤2 h after symptom onset, treated ≤3 h*86.285.488.187.185.6
IV tPA in patients who arrived <3.5 h after symptom onset, treated ≤4.5 h64.765.669.966.664.1
IV tPA door-to-needle time ≤60 min59.159.562.760.858.6
Thrombolytic complications: IV tPA and life-threatening, serious systemic hemorrhage16.320.08.314.718.1
Antithrombotic agents <48 h after admission*97.497.197.397.597.1
DVT prophylaxis by second hospital day*98.498.298.298.398.4
Antithrombotic agents at discharge*98.397.897.798.397.9
Anticoagulation for atrial fibrillation at discharge*94.394.394.894.694.0
Therapy at discharge if LDL-C >100 mg/dL or LDL-C not measured or on therapy at admission*96.096.496.096.795.5
Counseling for smoking cessation*96.896.595.996.896.4
Lifestyle changes recommended for BMI >25 kg/m255.552.657.555.254.6
Composite quality-of-care measure96.996.896.797.196.6
  • Values are percentages. BMI indicates body mass index; DVT, deep vein thrombosis; GWTG, Get With The Guidelines; IV, intravenous; LDL-C, low-density lipoprotein cholesterol; and tPA, tissue-type plasminogen activator.

  • * Indicates the 7 key achievement measures targeted in GWTG-Stroke.